Hangzhou Tigermed Consulting (03347) spent 3.2604 million RMB to repurchase 67,000 A shares on January 22nd.
Tiger Pharmaceuticals (03347) announced that it will spend 3.2604 million yuan (RMB) on January 22, 2025.
Hangzhou Tigermed Consulting (03347) announced that on January 22, 2025, it will spend 3.2604 million yuan to repurchase 67,000 shares of A-shares at a repurchase price of 48.54-48.97 yuan per share.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
